Log in to save to my catalogue

Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised contr...

Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised contr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808679526

Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up

About this item

Full title

Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up

Publisher

England: Elsevier Limited

Journal title

Annals of the rheumatic diseases, 2016-01, Vol.75 (1), p.30-36

Language

English

Formats

Publication information

Publisher

England: Elsevier Limited

More information

Scope and Contents

Contents

ObjectiveTo compare the efficacy of tacrolimus (TAC) and mycophenolate mofetil (MMF) for the initial therapy of lupus nephritis (LN).Study designThis is an open randomised controlled parallel group study.MethodsAdult patients with biopsy-confirmed active LN (class III/IV/V) were randomised to receive prednisolone (0.6 mg/kg/day for 6 weeks and tape...

Alternative Titles

Full title

Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1808679526

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808679526

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2014-206456

How to access this item